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Abstract
Background: Mobile phone text messaging (SMS) has the potential to promote adherence to tuberculosis
treatment. This systematic review aims to synthesize current evidence on the effectiveness of SMS interventions in
improving patients’ adherence to tuberculosis treatment.
Methods: We searched electronic databases (PubMed, EMBASE, Science Citation Index), reference lists of relevant
articles, conference proceedings, and selected websites for eligible studies available by 15 February 2013; regardless
of language or publication status. Two authors independently screened selected eligible studies, and assessed risk
of bias in included studies; resolving discrepancies by discussion and consensus.
Results: We identified four studies that compared the outcomes of the SMS intervention group with controls. Only
one of the four studies was a randomized controlled trial. This was conducted in Argentina and the SMS
intervention did not significantly improve adherence to tuberculosis treatment compared to self-administration of
tuberculosis treatment (risk ratio [RR] 1.49, 95% confidence intervals [CI] 0.90 to 2.42). One of the non-randomized
studies, conducted in South Africa, which compared SMS reminders to directly observed therapy short course
(DOTS) reported similar rates of tuberculosis cure (62.35% vs. 66.4%) and treatment success (72.94% vs. 69.4%). A
second study from South Africa, utilized SMS reminders when patients delayed in opening their pill bottles and
reported increased tuberculosis cure (RR 2.32, 95% CI 1.60 to 3.36) and smear conversion (RR 1.62, 95% CI 1.09 to 2.42)
rates compared to DOTS. In the third non-randomized study, conducted in Kenya, use of SMS reminders increased rates
of clinic attendance on scheduled days compared to standard care (RR 1.56, 95% CI 1.06 to 2.29). Using the GRADE
approach, we rate the quality of the evidence as low, mainly because of the high risk of bias and heterogeneity of
effects across studies.
Conclusions: This systematic review indicates that there is a paucity of high-quality data on the effectiveness of
SMS interventions for improving patients’ adherence to tuberculosis treatment. The low quality of the current
evidence implies that further studies (in particular randomized trials) on the subject are needed. In the interim, if
the intervention is implemented outside research settings an impact evaluation is warranted.
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Background
Tuberculosis (TB) is a major public health concern, with an
estimated 8.7 million incident cases and 1.4 million deaths
in 2011 [1]. The burden of TB is highest in 22 low- and
middle-income countries; mostly located in sub-Saharan
Africa, where TB is fuelled by the HIV/AIDS epidemic [2].
The World Health Organization (WHO) guidelines for
TB treatment recommend directly observed treatment
short course (DOTS) strategy to monitor patient medi-
cation adherence [1,3]. This strategy includes treating
TB using standardized rifampicin-based regimens of six
months duration for new TB cases and eight months for
retreatment cases. Failure of patients to complete TB
treatment results in infectivity, drug resistance, relapse
and death [4]. It is therefore important to find better
ways to improving patient adherence to TB treatment.
A variety of factors may impact on patient medication
adherence, and thus efforts to improve medication
adherence in general are more effective when they address
multiple dimensions of adherence behaviours than single-
target interventions [5,6]. Several strategies for promoting
TB medication adherence have been investigated. These
nclude interventions promoting better health care pro-
vider-patient communication about adherence; developing
or improving existing adherence support services that
are offered by a multidisciplinary team (nurse, physician,
pharmacy, patient etc.) [6]; directly observed therapy
(which involves a health care worker, community care
worker or family member directly monitoring patients
swallowing their TB medication) [4]; staff motivation and
supervision [4]; education and counseling [7]; reminder
systems and late patient tracers to help patients keep ap-
pointments [8]; incentives and enablers [9]; contracts (that
is written or verbal agreements) to return for appointment
or course of treatment; and social support to assist the pa-
tient in being adherent, provided by community healthcare
workers [10] or patient groups [6]. These interventions or
complex combinations of the interventions may need to be
employed to promote TB medication adherence.
The number of mobile phone subscriptions is growing
worldwide and stood at 6.6 billion at the end of 2012
[11]. In addition, the number of unique mobile phone
subscribers at the end of 2012 was estimated to be 3.2
billion, because of the use of on average 1.85 SIM cards per
individual and inactive SIM connections being included
by operators in their reported global mobile phone
subscription totals [12]. However, the number of mobile
phone users has continued to increase and is spreading
to the most remote areas in the world. Evidently, the
usefulness of mobile phone technology provides health-
care providers with an unprecedented opportunity to target
health interventions to people who would otherwise be
difficult to reach. Mobile phone text messaging, in
particular the short messaging service, may enable
healthcare providers to convey health information to pa-
tients and engage them in brief conversations. The short
messaging service (SMS) has recently been proposed as a
means of promoting TB medication adherence. For pro-
moting adherence to TB treatment, text-messages can be
sent daily or weekly to patients to remind them to take
their medication [13,14] through one way communica-
tion or two-way interactive communication (i.e. patients
can receive and reply to messages) [15-17]. Text-messages
may also be used to notify healthcare providers that
the patients have taken their medication [14,18,19]. In
addition, the text message intervention can be delivered
alone or bundled with economic incentives [14,19]. We
therefore conducted a review of the current best evidence
for the use of mobile phone text messaging to promote
patients’ adherence to TB treatment [20].
Methods
Criteria for considering studies for this review
Type of studies
We planned to include only randomized controlled trials
(RCTs), but later expanded the eligibility criteria to consider
non-randomized studies because of the paucity of the
former.
Types of participants
Adults (including pregnant women) or children receiving
treatment for TB infection, in any setting.
Types of interventions
We included interventions in which mobile phone text
messages were used to promote adherence to TB treatment.
The text messaging had to be delivered to a patient with
TB or, in the case of an infant or child, to a caregiver.
We also included studies in which the intervention was
compared to no intervention or other interventions for
promoting adherence. We excluded studies in which used
mobile phone voice speaking, voice messaging, a beeper, a
pager, or multimedia messaging service as interventions.
In addition, we excluded studies in which text messages
are bundled with other interventions unless it was possible
to separate the effects of text messaging alone.
Type of outcome measures
Primary outcomes The primary outcome for this review
was treatment adherence. We considered TB cure, suc-
cessful completion of TB treatment and drug resistance
development as proxies for adherence.
Secondary outcomes The secondary outcomes were
exposure to stigma associated with TB as a result of the
SMS revealing the patient’s disease status, and patient
satisfaction with the SMS intervention.
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Search methods for identification of studies
A comprehensive and exhaustive search was performed by
MN with the help of an information specialist, to identify
all relevant studies available by 15 February 2013 regardless
of language or publication status (published, unpublished,
in press, or in progress). We searched both peer-reviewed
journal articles and the grey literature (non-published/
internal or non-reviewed papers, reports).
Databases
We searched the following electronic databases: PubMed;
EMBASE; Cochrane Central Register of Controlled Trials
(CENTRAL); ISI Web of Science (Science Citation Index);
Africa-Wide Information; Cumulative Index of Nursing and
Allied Health (CINAHL); and World Health Organization
(WHO) library databases (WHOLIS). We used both text
words and medical subject heading (MeSH) terms, in
varying combinations. We adapted the search strategy
to suit each database. Additional file 1 shows detailed
information on the search strategy employed.
Conference proceedings
We also searched the proceedings of the Union World
Conference on Lung Health as well as the National Con-
ference on Tuberculosis and Chest Disease (NATCON).
In addition, we searched abstracts from the 2012 mHealth
Summit that were published in the Journal of Mobile
Technology in Medicine.
Searching other sources
We also searched the WHO International Clinical trials
Registry Platform, Clinicaltrials.gov, and the Pan African
Clinical Trials Registry (PACTR) for ongoing studies. In
addition, we searched the website of the mHealth Alliance
and the mHealth in Low Resource Settings' resources
database [21] for eligible studies. We also contacted The
AIDS Support Organization (TASO) and African Medical
and Research Foundation (AMREF) for information on
eligible studies that we may have missed.
Reference lists
We checked the reference lists of full-text articles assessed
for inclusion in the review.
Data collection and analysis
The methodology for data collection and analysis was based
on the guidance of the Cochrane Handbook of Systematic
Reviews for Interventions [22].
Selection of studies
We developed and piloted a screening guide to ensure
that the inclusion criteria are adhered to and consistently
applied by all review authors. Two review authors (MN
and CW), working independently, screened the titles and
abstracts of all studies identified through the literature
searches for eligibility. MN obtained full text of studies
deemed potentially eligible by one or both authors. The
two authors then independently assessed the full text of
each article for eligibility, compared their results, and
resolved discrepancies by discussion and consensus. For
all studies excluded by the assessors, we have provided the
reasons for exclusion in Table 1.
Data extraction and management
References were managed using Thomson ISI Research-
Soft Endnote 9.0 [23]. Two authors independently ex-
tracted descriptive and outcome data for each included
article using a standardized data collection form, resolving
any discrepancies by discussion and consensus. MN
entered the final data into the Cochrane Collaboration
Review Manager Version 5.2 statistical software [24]. CW
cross-checked the data entered to ensure that there were
no data entry errors.
Assessment of risk of bias in included studies
Two authors (MN and CW) independently assessed
the risk of bias in the included studies, by evaluating
random sequence generation (for RCTs only), allocation
concealment (for RCTs only), blinding of outcome as-
sessors (for all studies), incomplete outcome data (for
all studies), selective outcome reporting (for all studies),
and other sources of bias (for all studies); in accordance
with the methods by the Cochrane Collaboration [22].
Therefore, the assessment of risk of bias took into account
the variation in study designs (i.e. RCTs and non-random-
ized studies), as certain criteria were only applicable to
RCTs and others were applicable to both RCTs and
non-randomized studies. Studies were scored as having
a low, high, or unclear risk of bias. The two authors
Table 1 Characteristics of excluded studies
Study Reason for exclusion
Mohammed [27] No appropriate control group.
Mahmud [33] Text messaging intervention was delivered
to community health care workers in order
to improve patient-physician communication.
Therefore, the study did not assess the use of
SMS text messaging for promoting adherence
to TB treatment in patients.
Person [28,29] No appropriate control group.
Liu [34] The study did not report any of the outcomes
of interest.
Kao [30] This is a descriptive study. No appropriate control
group.
Batra [31] No appropriate control group.
Hoffman [35,36] A pilot study in which text messages are bundled
with video messages and is not possible to
separate the effects of the text messages alone.
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resolved disagreements in the assessment of risk of bias
by discussion and consensus.
Measures of treatment effect
Data analysis was conducted using the Cochrane Collab-
oration Review Manager Version 5.2 statistical software
[24]. The outcomes of interest were all dichotomous. We
calculated risk ratios (RR) and their corresponding 95%
confidence intervals (CI) and p-values, when count data
were available.
Dealing with missing data
In cases of missing or incomplete information presented
in included studies, we attempted to contact authors for
further information.
Data synthesis and investigation of heterogeneity
We assessed clinical heterogeneity by examining types of
participants, interventions and outcomes in each study.
We also assessed methodological heterogeneity by exam-
ining differences between studies in methodological factors
such as the comparability of groups. All included studies
were judged to be clinically and methodological hetero-
geneous, and we decided to preclude meta-analysis and
describe findings for each study individually. Finally,
we used the Grading of Recommendations Assessment,
Development, and Evaluation (GRADE) approach [25,26]
to assess to the quality of evidence for the effectiveness
of the SMS intervention. This method results in an
assessment of the quality of the body of evidence as high,
moderate, low, or very low. Evidence is considered of high
quality if “further research is very unlikely to change our
confidence in the estimate of effect”, and moderate quality
if “further research is likely to have an important impact
on our confidence in the estimate of effect and may
change the estimate”. Low quality evidence implies that
“further research is very likely to have an important
impact on our confidence in the estimate of effect and
is likely to change the estimate”, and very low quality that
“we have very little confidence in the effect estimate”.
Sensitivity analyses
We did not conduct a meta-analysis, and could therefore
not perform sensitivity analyses.
Presenting and reporting of results
We have presented our findings in several ways. We have
provided a flow diagram that summarizes the study selec-
tion process (Figure 1), a table of characteristics included
studies (Table 2), and a risk of bias table (Table 3) and
graph (Figure 2). In addition, we have provided a descrip-
tive report of outcomes that do not have quantitative data
and assessed the certainty of the evidence of effectiveness
using the GRADE approach. Lastly, we have provided a list
of excluded studies with reasons for exclusion (Table 1).
Results
Study flow and description of studies
The process and results of study identification are outlined
in a flow diagram (Figure 1). We identified 132 records
through a comprehensive search. We removed 35 dupli-
cates and screened 97 titles and abstracts. We excluded 81
clearly irrelevant records, and reviewed 16 full-text articles
and abstracts for eligibility. Among the potentially eligible
records, seven studies reported in nine publications were
excluded with reasons given below, four studies met our
inclusion criteria, and three are ongoing studies.
Excluded studies
We obtained the full text of 16 potentially eligible arti-
cles; from which we excluded 9 articles, representing 7
individual studies. Studies conducted by Mohammed and
colleagues [27], Person and colleagues [28,29], Kao and
colleagues [30] and Batra and colleagues [31] were
excluded because of the absence of an appropriate control.
The study by Mahmud and colleagues [32,33] was excluded
because the text messaging intervention was delivered to
community healthcare workers rather than patients. The
study by Liu and colleagues [34] was excluded because it
did not mention any outcomes considered in this review.
The study by Hoffman and colleagues [35,36] was excluded
because text messages were bundled with video messages
and it was not possible to separate the effects of text messa-
ging alone. We provide the reasons for excluding each of
these publications in Table 1.
Included studies
We provide detailed information of included studies in
Table 2, and summarize key features below.
The non-governmental organization Bridges.org con-
ducted a pilot study in South Africa in which daily SMS
reminders were used to remind patients who self-adminis-
ter their medication (i.e. not on DOTS) to take their drugs
[37]. The pilot study started in January 2002 and as of
March 2005 had enrolled over 300 new smear positive TB
patients at the clinic, with more than 280 having com-
pleted their 6-month course of anti-tuberculosis therapy
(or 8-month course for retreatment TB). Health outcome
data were only available for 221 TB patients. The health
outcomes data for the 221 TB patients receiving SMS re-
minders were compared with that of controls (all smear-
positive patients attending clinic-based DOTS who had
health outcomes data for the third quarter of 2003). Brid-
ges.org did not report the number of controls. This pre-
cluded the calculation of a risk ratio and its confidence
intervals for this review. Bridges.org found the SMS inter-
vention and the clinic-based DOTS groups were similar
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with regard to rates of TB cure (62.35% vs. 66.4%) and
treatment success (72.94% vs. 69.4%); but the rate of
completion of TB treatment was slightly higher in the
SMS intervention group compared to the clinic-based
DOTS group (10.59% vs. 3.0%). Bridges.org believed that
the pilot produced similar results that are normal for the
clinic but did not demonstrate a significant improvement.
Numerous issues were attributed to the lack of additional
benefit of the SMS reminders. These included problems in
monitoring treatment adherence; lack of ownership of
the service at the clinic due to the lack of proactive
participation of staff; lack of regular feedback and
interaction among all stakeholders and the fact that a
significant number of patients failed to use the service
as instructed.
Bridges.org also evaluated patient satisfaction with the
SMS intervention among 26 participants using structured
questionnaires. The study authors found that most patients
were satisfied with the SMS reminders. The patients
reported feeling “good to think nurses at the clinic care
enough to SMS you every morning” and feeling “more
connected to the clinic than usual”, and one patient felt
that she/he “would definitely forget to take my tablets if I
didn't get an SMS from the clinic [37].
Broomhead and Mars [38] conducted a retrospective
analysis of a 2005 pilot study of smear positive TB patients
commencing a 6-month course of anti-tuberculosis
therapy in South Africa, in which health outcomes in
patients given a wireless pill bottle (SIMpill®) that sends an
SMS to a central server notifying it of the patient taking
their medication (plus standard DOTS) were compared
with matched controls who received standard DOTS only.
Frequency matching was utilized to match participants
from the pilot study with controls in a 1: 4 ratio. We
analyzed participants according to whether or not they
received SMS reminders. Rates of sputum smear conver-
sion and TB cure were provided for two scenarios. Scenario
one included all 24 participants who took part in the pilot
and their 96 controls. Scenario two excluded 6 participants
that took part in the pilot but who subsequently died, along
with their 24 matched controls, thereby reducing the
cohorts to 18 participants from the pilot and their 72
controls. We used health outcomes data from scenario one
for this systematic review. The study found significantly
higher sputum smear conversion rates among those who
received standard DOTS in combination with SIMpill®
than those who received only standard DOTS (RR 1.62,
95% CI 1.09 to 2.42). The study also found significantly
higher TB cure rates in the SIMpill® - DOTS group than
in the DOTs only group (RR 2.32, 95% CI 1.60 to 3.36).
These findings suggest that there was improved treatment
adherence when using SIMpill® in combination with stand-
ard DOTS than when using standard DOTS alone [38].
Owiti and colleagues [39], in a pilot feasibility study
from Kenya, assessed the use of SMS reminders to improve
clinic appointment compliance. Rates of scheduled clinic
Duplicates removed 
N=35
Titles and abstracts screened
N=97
Full-text articles reviewed for eligibility
N=16
Clearly irrelevant records excluded
N=81
Excluded studies, with reasons 
N=9
Ongoing studies 
N=3Studies included in the review
N=4
Identified through comprehensive search
N=132 records
Figure 1 Flow chart for studies in the systematic review. Flow chart showing the process and results of study identification.
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Table 2 Characteristics of included studies
Study ID Bridges.org [37]
Methods The evaluation used both qualitative and quantitative data collection methods. Structured interviews using a
questionnaire were conducted among patients and staff. Additional information was collected from patient
records, background documents and reports and clinic visits.
Participants Patients, clinic staff, TB experts and managers at the City of Cape Town Health Directorate.
Interventions Daily SMS reminders were used to remind patients who self-administer their medication (i.e. not on DOTS) to
take their drugs.
Outcomes 1) Health Outcomes serve as a proxy for TB treatment adherence
On Cue Compliance service (from 221 patients with records available):
Cure rate = 62.35%
Completion rate = 10.59
Treatment success rate = 72.94%
Clinic-based DOTS (in particular new smear-positive TB patients in the third quarter of 2003):
Cure rate = 66.4%
Completion rate = 3.0%
Treatment success rate = 69.4%
Health outcomes between groups were similar.
2) Patient satisfaction with the SMS intervention
Notes
Study ID Broomhead [38]
Methods A retrospective analysis comparing the costs and health outcomes of the DOTS-SIMPill cohort with DOTs-only
controls.
Participants 24 New smear-positive TB patients who presented to Betty Gaetsewe Clinic and commenced the 6-month
treatment on first line and anti-TB medication enrolled for SMS based medical adherence support (MAS) pilot
in 2005 and 96 DOTs-only control patients presenting for the months during the pilot was running.
Frequency matching was used to match MAS pilot participants with controls in a 4:1 ratio. Matching was on
TB treatment, local clinic, gender and age.
Interventions Intervention:
MAS system. It consists of a device that attaches to the standard pill bottle or blister pack and sends an SMS
every time the patient opens the bottle to a Web-base application. This is taken as a proxy for TB treatment
adherence.
Control:
DOTS-only controls
Outcomes Health outcomes (i.e. smear conversion rate and TB cure rate) served as a proxy for TB treatment adherence
MAS group:
Smear conversion rate = 62.5%
TB cure rate = 75.0%
Control group:
Smear conversion rate = 38.4%
TB cure rate = 32.3%
Both the smear conversion rate and TB cure rate were significantly higher for the MAS group compared with
the control group
Smear conversion rate: RR 1.62 (95% CI 1.09-2.42)
TB cure rate: RR 2.32 (95% CI 1.60 – 3.36)
Notes
Study ID Iribarren [40]
Methods A parallel design randomized control pilot study
Participants 37 newly diagnosed TB patients (18 in the intervention group and 19 in the control group)
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appointment attendance were compared between patients
receiving and those not receiving (for technical reasons)
SMS reminders. The text messages were sent in Ki-Swahili
one day prior to their clinic appointments using Frontline
SMS platform. We took the rate of clinic appointment
attendance on scheduled days as a proxy for adherence. In
this study, 150 patients received at least one SMS reminder
and 37 did not receive an SMS. Those who received an
SMS reminder were 1.6 times more likely to adhere to
scheduled clinic appointment compared to those who did
not (95% CI 1.06 to 2.29) [39].
Iribarren and colleagues [40], in a pilot parallel de-
sign randomized control study among newly diagnosed
TB patients commencing anti-tuberculosis treatment
in Argentina, randomly assigned 19 patients to standard
care (self-administration of medication) and 18 to the
intervention arm. The intervention arm received standard
care and a SMS-based intervention which included ins-
tructing patients to “text-in” after self-administration of
medication; delivery of SMS reminders when patient did
not “text in”; and receipt of a bi-weekly SMS providing
educational information and the option to consult during
the first two-month intensive treatment phase. Educational
text messages were selected based on the Informational-
Motivational-Behavioral Skills Model. Text messages were
sent using FrontlineSMS, which is a free automated SMS
platform. The outcome of interest for this systematic
review was self-reported adherence (as measured using
notification rates over a 60-day period for the intervention
arm and receipt of medication calendars at 60 days for the
control arm). The analysis was by intention to treat. At
60 days, patients in the intervention group had a higher
self-reported adherence rate than those in the control
group, but this difference was not statistically significant
(RR 1.49, 95% CI 0.90 to 2.42) [40].
Risk of bias in included studies
We considered the methodological quality of the included
studies to be generally poor. Three studies were observa-
tional in nature and one was a pilot randomized controlled
Table 2 Characteristics of included studies (Continued)
Interventions Intervention:
Standard Care plus a SMS-based intervention which included instructing patients to “text in” after self-administration
of medication; reminders/check-in when patient did not “text in”; receipt of bi-weekly SMS education messages;
and the option to consult during the first two months intensive treatment phase.
FrontlineSMS network was employed.
Control:
Self-administration of TB treatment (standard of care)
Outcomes Of the intervention group, 77% (22%-100%) notified (i.e. self report via text message) that they took their
medication over a 60 day period. The control group was asked to complete medication calendars over the same
period but only 53% of them returned the calendars. We found that the SMS intervention did not statistically
improve adherence to TB treatment (RR 1.49 [95% CI 0.90-2.42]).
Notes Additional information obtained from the primary author. The full article for the corresponding conference
abstract is yet to be published.
Study ID Owiti [39]
Methods A feasibility pilot study
Participants 187 TB patients with mobile phones
Interventions Intervention:
Receiving text messages in Ki-Swahili which were delivered one day prior to the patients’ clinic appointment
Control:
Not receiving text messages (due to technical reasons)
Clinic attendance on scheduled days
Outcomes ● Received at least one text: 101/150
● Did not receive a text (due to technical reasons): 16/37
RR 1.56 [95% CI 1.06-2.29]; p-value <0.0007.
Notes ● We noted an error in the table presented by the authors which occurred in the rows for males and females,
in particular, the cell containing data for males who did not receive a text message were transposed with that
containing data for females who received at least one text message. However, we did not use that information.
Instead, we used the data in the total row, that was corroborated with the information in the abstract text.
● The full article for the corresponding conference abstract is yet to be published
(Dr P. Owti, personal communication)
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Table 3 Risk of bias in included studies
Study ID Bridges.org [37]
Bias Authors judgment Support for judgment
Blinding of participants and personnel (performance bias) Unclear risk Blinding of participants and study personal were not reported.
Blinding of outcome assessment (detection bias) Unclear risk The blinding of outcome assessors was not specified.
Incomplete outcome data (attrition bias) Unclear risk 88/309 missing from the intervention group; missing data are
not reported for the control group. It remains unclear whether
the proportion of missing data was balanced across groups
Selective reporting (reporting bias) Low risk The outcome reporting in the study report was comparable
with the outcomes pre-specified in the methods.
Other bias Unclear risk Given the observational nature of the study there might be
confounding variables that were not accounted for in the analysis
(comparisons for health outcomes which serve as a proxy for TB
treatment adherence)
Study ID Broomhead [38]
Bias Authors judgment Support for judgment
Blinding of participants and personnel (performance bias) Unclear risk Blinding of participants and study personal were not reported.
Blinding of outcome assessment (detection bias) Unclear risk The blinding of outcome assessors was not specified.
Incomplete outcome data (attrition bias) Low risk No missing data in both the intervention and the control group.
Selective reporting (reporting bias) High risk Comparisons for health outcomes (i.e. smear conversion rate,
cure rate and MDR TB rate) mentioned in text in the results but
only smear conversion rate and cure rate (with significant results)
were reported in the table.
Other bias Unclear risk Given the observational nature of the study there might be
confounding variables that were not accounted for in the analysis
(comparisons for health outcomes which serve as a proxy for TB
treatment adherence)
Study ID Iribarren [40]
Bias Authors judgment Support for judgment
Random sequence generation Unclear risk The random sequence generation process was not described.
Allocation concealment Unclear risk The method of concealment was not described.
Blinding of participants and personnel (performance bias) Unclear risk Blinding of participants and study personal were not reported.
Blinding of outcome assessment (detection bias) Unclear risk The blinding of outcome assessors was not specified
Incomplete outcome data (attrition bias) High risk Additional information obtained from the primary author revealed
that no data are missing for the intervention group and 9/19 for
the control group. Reasons for missing data were due to
non-responsiveness of the intervention group.
Selective reporting (reporting bias) High risk Initial efficacy outcomes (notification rates and sputum conversion
rates) and patient acceptability were mentioned in the methods,
but only patient notification rates, follow sputum smear culture
and patient acceptability reported in the results. Additional
obtained from the primary author revealed that data on the
final outcomes are yet to be collected and published.
Other bias Unclear risk The lack of description of the random sequence generation
process and the method of concealment suggests that there
might be confounding variables that were not accounted for
in the analysis (comparisons for TB treatment adherence)
Study ID Owiti [39]
Bias Authors judgment Support for judgment
Blinding of participants and personnel (performance bias) Unclear risk Blinding of participants and study personal were not reported.
Blinding of outcome assessment (detection bias) Unclear risk The blinding of outcome assessors was not specified
Incomplete outcome data (attrition bias) Low risk No missing data in those receiving text reminders and not
receiving text reminders
Selective reporting (reporting bias) Unclear risk Inadequately information provided as this was a conference
abstract.
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trial. In two studies we used treatment outcomes as a
proxy for treatment adherence while in the remaining two,
we assessed treatment adherence by notification rate and
clinic appointments respectively. For random sequence
generation, the RCT was judged to have an unclear risk of
bias because the study did not describe the process used
to generate the randomization sequence. For allocation
concealment, the RCT was judged to have an unclear risk
of bias because the method used to conceal treatment
allocation was not described. The blinding of participants
and personnel was not reported in the RCT and the
study was judged to have an unclear risk of bias for this
component. The blinding of outcome assessors was not
specified in any of the studies and the risk of bias being in-
troduced to the studies at the time of outcome assessment
was judged to be unclear. Regarding completeness of out-
come data, one study was judged to have an unclear risk
of bias because it was unclear whether the proportion of
missing data was balanced across intervention groups.
Two studies were judged to have a low risk of bias be-
cause there were no missing data. One study was judged
to have a high risk of bias because no data were missing
in the intervention group but 47.3% (9/19) of data were
missing in the control group. This information was
obtained from email communication with the study
authors. Two studies had selective reporting of outcomes
and were judged to have a high risk of bias. One study had
inadequate information provided on selective outcome
reporting and was judged to have an unclear risk of bias,
while another had no selective outcome reporting and was
judged to be at low risk of bias. Given the observational
nature of three of the included studies, there might be
other confounding variables not accounted for in the
analyses. Therefore, these studies were not judged to be
free from other sources of bias. For the included RCT, the
lack of description of the random sequence generation
process and the method of allocation concealment sug-
gests that there might be other confounding variables not
accounted for in the analysis. We provided a detailed
analysis of the risk of bias in Table 3 and Figure 2.
Effects of intervention
A meta-analysis of data from included studies was not
done because of significant clinical and methodological
heterogeneity among the studies. Findings for each study
are described individually. Bridges.org 2005 [37] found
that the SMS intervention and the clinic-based DOTS
groups were similar with regard to rates of TB cure
(62.35% vs. 66.40%) and treatment success ( 72.94% vs.
69.4%). However, the rate of completion of TB treatment
was higher in the SMS intervention compared to the
clinic-based DOTS group (10.59% vs. 3.00%). Broomhead
Figure 2 Cochrane risk of bias summary: review authors’ judgment about each risk of bias item for each included study. Cochrane risk
of bias summary for included studies.
Table 3 Risk of bias in included studies (Continued)
Other bias Unclear risk Given the observational nature of the study there might be
confounding variables that were not accounted for in the
analysis (comparisons for scheduled clinic appointment
attendance which serves as a TB treatment adherence)
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[38] showed a higher TB cure rate among patients receiving
standard DOTS plus SIMpill® than those receiving standard
DOTS only (RR 2.32, 95% CI 1.60 to 3.36). The same study
also found a higher sputum smear conversion rate among
patients receiving standard DOTS plus SIMpill® compared
to those receiving standard DOTS only (RR 1.62, 95% CI
1.09 to 2.42). Owiti [39] found increased rates of clinic
attendance on scheduled days among patients receiving
SMS reminders compared to those who did not (RR 1.56,
95% CI 1.06 to 2.29). Iribarren [40] found that self-reported
adherence was higher the SMS-based intervention group
than in the standard care group, but this difference was not
statistically significant (RR 1.49, 95% CI 0.90 to 2.42).
Ongoing studies
As indicated earlier, we found three ongoing RCTs. An
RCT to evaluate the impact of SMS text messages on
adherence to treatment for latent TB is currently ongoing
in British Columbia, Canada [41]. In Karachi, Pakistan,
an RCT is currently underway to assess the impact of
interactive reminders on drug compliance and treatment
outcomes [42]. Another RCT is currently underway in
China to assess the impact of mobile phone text messages
on TB treatment adherence [43]. We provide more infor-
mation on these ongoing RCTs in Table 4.
Discussion
Four studies with a total of 565 participants were included
in this systematic review. Three studies were observational
in nature and only one was a randomized controlled trial.
A meta-analysis could not be performed because there
was significant clinical and methodological heterogeneity
in the included studies. Overall, the included studies
suggest that patients receiving mobile phone text messa-
ging interventions had rates of adherence to TB treatment
comparable to or higher than those receiving no interven-
tion. Therefore, the findings provide mixed evidence for the
effectiveness of mobile phone text messaging interventions
designed to promote adherence to TB treatment.
Though the evidence is mixed, we cannot ignore the
potential of mobile phone text messaging to transform the
delivery of health messages to patients. Mobile phones
have spread globally; 45% of the world’s population were
estimated to have access to a mobile phone at the end of
2012 [12,44]. In addition, the use of SMS has become
popular throughout the world. Globally, there were an
estimated 5.9 trillion SMS messages sent in 2011 and SMS
traffic is expected to reach 9.4 trillion messages by 2016
[45,46]. This increasingly popular mode of communication
can be used to deliver short health messages to people
anywhere and provide interactive feedback and support to
people when they need it the most. Previous research has
shown that SMS interventions are effective as a means to
promote multiple healthy behaviors such as adherence to
antiretroviral treatment [13], diabetes management and
control [47], smoking cessation [48], and immunization
compliance [49-51]. We have found that currently avail-
able research utilizing SMS interventions to promote
adherence to TB treatment is inconclusive.
Overall completeness and applicability of evidence
The strength of this systematic review lies in our adherence
to international standardized guidelines on the conduct
and reporting of systematic reviews [22]. However, due to
paucity of published data, the majority of studies in our
sample were from the grey literature. Only one of the four
included studies was peer-reviewed. One of the remaining
three was a non-published report and two were conference
abstracts. These publications have not undergone peer
review and may therefore include selective reporting biases.
Only one study included in this review was an RCT and
the others were observational in nature.
Quality of the evidence
Knowledge of the best available evidence is essential for
policymakers, patients and clinics in making informed
health care decisions. We used the GRADE system [25,26]
to assess the quality of evidence in this review. Overall,
the quality of the available evidence on the use of SMS
interventions to promote patient TB treatment adherence
is low. The implication of the low-quality evidence is that
further improved quality research (in particular RCTs)
is needed to enhance our level of certainty in the effective-
ness of SMS interventions to improve adherence to TB
treatment. The main reasons for rating down the quality
of evidence were a high risk of bias and heterogeneity of
effects across included studies.
Potential biases in the review process
Although this systematic review adheres to the standard-
ized guidelines of conduct and reporting of systematic
reviews [22], there are certain limitations. Although we
did not set out to exclude non-English studies in this re-
view, non-English studies may have been missed because
they are less commonly indexed in the selected databases
compared to English studies. In addition, unpublished
eligible studies may have been missed. Factors which
tend to influence publication are statistically significant
results, size of the study, funding, prestige, type of design
and study quality [52]. We found that the majority of
publications were retrieved from the grey literature, and
these publications may have been systematically different
from those in journal articles, which have undergone
scrutiny prior to publication. We have also, due to the
paucity of available research, included studies that were
pilot or feasibility studies. These studies often have nu-
merous design issues, including small sample sizes, poor
reporting, and lack of an appropriate control group [53];
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Table 4 Characteristics of ongoing studies
Item/study Lester [41] Mohammed [42] Jiang [43]
Trial name or title A Randomized Controlled Trial
to Examine the Effectiveness of
Use of Mobile Phones and Text
Messaging to Improve Adherence
to Treatment of Latent TB
Monitoring Patient Compliance
with Tuberculosis Treatment
Regimens
Cluster randomized trial of using
mobile text messaging and a
medication monitor in tuberculosis
(TB) case management
Methods Open-label multicenter
randomized controlled trial
Allocation: Randomized, Intervention
Model: Parallel Assignment, Masking:
Open Label, Primary Purpose:
Supportive Care.
Cluster Randomized Controlled Trial
Participants Subjects initiating treatment for
latent TB infection who are aged
above 18 years, who own a
mobile phone or share mobile
phone access with a household
member who consents to
participate. In addition, the
subject should be able to read
text-messages in English or has
a family member or friend that
can provide translation and
assistance with text-messages
during the duration of the study
Inclusion criteria: Inclusion criteria:
● New, spear-positive drug
susceptible TB patients who have
been on treatment for less than
two weeks
● TB patients, smear-positive or
smear-negative, recruited from
the study clusters (county/district)
● 15 years and older ● Willing to participate in the study
● Conscious without any mental
disease
● Access to a mobile phone
(self-report)
● Conscious without any visual,
auditory or language impairment
● At least 18 years old
● Intending to reside in Karachi for
the duration of treatment
● Patient or family member is
able to read a short message
service (SMS)/ text and use
medication monitor after trainingExclusion criteria:
Exclusion criteria:
● Does not meet inclusion criteria
● Patients who do not have regular
access to a mobile phone
● Patients with tuberculosis pleurisy
● Patients with no sputum smear
data at tuberculosis diagnosis● Patients who have previously
received treatment
Patients who have another member
in their household who is already a
part of the study
Interventions Weekly text messages will be
sent to the participants in the
intervention arm asking them
how they are
Other: Interactive Reminders This is a cluster randomized non
blinded trial. Clusters are defined
as a county or district. This is a
four armed trial, three intervention
arms and one control arm:
Daily SMS reminders sent to TB
patients at a pre-specified time.
They are asked to respond to the
reminders. If a response is not received
within two hours, they are sent
another reminder for up to three
hours per day
1. Mobile phone
Patients are provided with mobile
phones as a reminding tool to
take their tuberculosis medication.
On medication intake days patients
are sent a SMS to remind them to
take their medication. They respond
with a brief message when
medication is taken. Doctors in TB
dispensary collect the SMS feedback
from patients to assess how many
doses are missed in a month. Based
on the missed doses, additional
intervention and incentive
mechanisms are implemented such
as visits from the township/village
doctor and incentives per visit given
to the township/village doctor.
2. Medication monitor
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Table 4 Characteristics of ongoing studies (Continued)
Patients are provided with a
medication monitor box with
reminding functions. This tool is
used to remind patients to their
tuberculosis medication and also
records drug intake. Doctors at
the TB dispensary collect the drug
intake record from medication
monitor monthly to assess that
how many doses are missed in a
month. Based on the missed doses,
additional intervention and incentive
mechanism are implemented as
described in the mobile phone
intervention (1)
3. Mobile phone and medication
monitor
Patients are provided with both
the mobile phone and medication
monitor box with reminding function
for as tools for communication,
reminding and recording drug
intake. The drugs intake record
from medication monitor and
SMS from patients are collected
monthly, and the number of doses
missed in a month is calculated
using the drug intake record of the
medication monitor. Based on the
missed doses, additional intervention
and incentive mechanism are
implemented as described in the
mobile phone intervention (1)
4. Control
Patients are managed based on
the current standard of care.
All patients will be followed up to
the end of tuberculosis treatment.
Outcomes Primary outcome: Successful
completion of LTBI treatment
regimens. [Time Frame: 4 or
9 months]. Successful treatment
completion is defined as taking
at least 80% of the doses of INH
prescribed within 12 months or
at least 80% of the disease of RIF
prescribed within 6 months
Primary outcomes: Primary outcome:
● Treatment Outcomes [Time Frame:
After 6 to 8 months of treatment]
[Designated as safety issue: No]. The
investigators will compare clinically
reported treatment outcomes
between the intervention and
control groups.
● The mean proportion of months
on TB treatment where at least 3
doses were missed in a month
(this is based on pill count data
from the medication monitoring box)
● Sputum conversion [ Time Frame:
At 2, 5, and 6/7 months of treatment ]
[ Designated as safety issue: No ]The
investigators will look at sputum test
results for patients at months 2, 5,
and 6/7 of their treatment to compare
when sputum conversion occurs
between the intervention and control
group at these three periods during
their treatment.
Secondary outcomes:
● The mean proportion of months
a patient has at least 7 doses missed
● The mean proportion of overall
missed doses
● Treatment compliance [Time Frame:
Monthly visits for 6 to 8 months of
treatment ] [ Designated as safety issue:
No ]The regularity of treatment will be
measured using urinalysis tests that
detect the presence of isoniazid or
rifampicin, a first line drug for TB
treatment, in patients' urine. These
● Proportion of patients defined
as non-adherent (at least 10% of
doses missed)
● Proportion of patients defaulting
during TB treatment
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which may influence the size of the effect estimate and the
quality of the evidence.
Agreement or disagreements with other studies
or reviews
A previous narrative review by Denkinger et al. [54] has
summarized the recent developments at the intersection
of TB care and control and m-Health, including evi-
dence from PubMed, grey literature mentioned in the
reference lists of articles, and additional studies that
were identified from experts in the field. Our system-
atic review has a particular focus on the use of SMS
interventions to promote patient adherence to TB treat-
ment, is more up to date, and provides evidence-based
conclusions.
Comparison to the literature on the use of mobile phone
text messaging for improving adherence to antiretroviral
medication
There is very little peer-reviewed literature available on
the use of mobile phone text messaging to improve
anti-tuberculosis medication adherence. In contrast, there
is relatively more peer-reviewed literature available on the
use of SMS-based platforms for improving adherence
to antiretroviral treatment [13,55] A systematic review
published in 2012 that included two RCTs on the use of
mobile phone text messages to promote antiretroviral
medication adherence found that weekly mobile phone
text messaging significantly improved adherence to anti-
retroviral medication in HIV infected patients, compared
to standard care [13]. However, an RCT from Cameroon
published in the same year that was not included in the
Table 4 Characteristics of ongoing studies (Continued)
results will be collected through
monthly "surprise" visits to the
participants' houses. The number of
negative results will be compared
between treatment and control groups.
● Proportion of smear positive
TB cases who become smear
negative at 2 months
Secondary outcomes:
● Physical fitness and mobility
[Time Frame: Monthly visits for 6 to
8 months of treatment] [Designated
as safety issue: No].The investigators
will measure physical fitness and
mobility through questionnaires
conducted with patients during
household visits each month that
they are on treatment. The investigators
are using two indices. The physical
fitness index will record respondents’
ability to perform certain tasks. The
mobility index will record the mobility
of participants.
● The proportion of patients with
treatment outcome of cure or
completed treatment
● Psychological Impacts [ Time Frame:
Monthly visits for 6 to 8 months of
treatment ] [ Designated as safety
issue: No ]In order to gauge the
psychological impacts of the system,
the investigators will be looking at
participants' perceptions on the
likelihood of being cured, how they
feel on a given day using the pain
scale, and how supported they feel.
This data will be collected through
questionnaires conducted at each
monthly mid-line visit.
Starting date April 2012 2011 2011
Estimated study
completion date
December 2014 November 2014 August 2012
Contact information Richard Lester:
richard.lester@bccdc.ca
Natasha Van Borek:
natasha.vanborek@bccdc.ca
Shama Mohammed:
shama.mohammed@irdresearch.org
Professor Shiwen Jiang:
jiangsw@chinatb.org
Notes ClinicalTrials.gov identifier:
NCT01549457
ClinicalTrials.gov identifier:
NCT01690754
Current Controlled Trials identifier:
ISRCTN46846388
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aforementioned systematic review found that standardized
motivational text messaging did not significantly improve
adherence to antiretroviral treatment in HIV-infected
patients, compared to standard care [55]. Studies inves-
tigating the use of SMS interventions as an aid to pro-
moting adherence to medication in resource-limited
settings will need to take into account barriers such as
low-literacy levels; language barriers; lack of access to the
owner of a mobile phone given that sharing of mobile
phones is common in many places; restrictions on the
content of text messages; issues such as habituation and
the ignoring of messages when text messages are delivered
too frequently; privacy and disclosure issues; poor mobile
phone service provision [17,56,57]; the inability of mobile
phone users to charge their phones due to lack of electri-
city; the inability to buy pre-paid phone cards; and the
high incidence of mobile phone theft and phone number
changes in some parts of the world.
Implication for practice
Whilst some of the formative research presented here
as part of this systematic review of mobile phone text
messaging and its efficacy in enhancing adherence in TB
programs shows promise, and although this intervention
is likely to be light on resources, the inconclusive evidence
of efficacy implies that this intervention should not yet be
scaled up in TB programs outside research settings.
Implication for research
The paucity of data and the imprecise methodology
encountered in the research in this field to date suggest
that there is room for more carefully designed research.
Future studies should have standardized outcome measures
such as TB cure, successful completion of TB treatment,
and development of drug resistance. Considered in this
systematic review but not found, is the potential for
stigmatization and disclosure that are inherent risks in
this kind of intervention. These (perceived) risks may
undermine efficacy and acceptability and should therefore
be studied. In addition, future studies need to pay attention
to the reporting of the delivery of the intervention i.e.
length of messages, content of messages, timing of mes-
sages, frequency of messages, SMS platform used to send
messages (automated versus manual), and two-way versus
one-way communication. These factors may influence effi-
cacy, acceptability, cost, and scale up. Although mobile
phone text messaging is attractive in that it is relatively
inexpensive, cost of development, implementation and
maintenance needs to be considered and weighed against
effectiveness. In addition, since RCTs are the gold standard
for testing the effect of an intervention, it would be useful
to see more RCTs on this subject. It is encouraging that
three RCTs are currently underway in Canada, Pakistan
and China [41-43].
Conclusions
The findings of this systematic review indicate that SMS
interventions have a potential for use to improve patients’
adherence to TB treatment, though the evidence is incon-
clusive. To conclude that such an intervention is effective
is difficult because there is a paucity of high-quality
studies. The current evidence is of low quality implying
that further research is very likely to have an important
impact on our confidence in the effectiveness of this
intervention and is likely to change the magnitude of the
estimate of effect. The results of the systematic review also
lay an important foundation on which future studies can
build upon. Future studies (in particular RCTs) should be
of robust methodology, well reported and interventions
optimized in order to establish their benefit. We will
update this systematic review when new evidence emerges
from the three ongoing studies.
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